Wellington Management Group’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$158M Buy
918,095
+330,332
+56% +$57M 0.03% 413
2025
Q1
$91.6M Sell
587,763
-116,412
-17% -$18.1M 0.02% 526
2024
Q4
$96.9M Sell
704,175
-557,305
-44% -$76.7M 0.02% 537
2024
Q3
$188M Sell
1,261,480
-1,351,376
-52% -$202M 0.03% 408
2024
Q2
$356M Sell
2,612,856
-133,016
-5% -$18.1M 0.06% 259
2024
Q1
$415M Sell
2,745,872
-502,421
-15% -$76M 0.07% 252
2023
Q4
$409M Sell
3,248,293
-28,879
-0.9% -$3.64M 0.08% 246
2023
Q3
$307M Buy
3,277,172
+128,272
+4% +$12M 0.06% 283
2023
Q2
$281M Buy
3,148,900
+215,108
+7% +$19.2M 0.05% 321
2023
Q1
$315M Sell
2,933,792
-119,813
-4% -$12.8M 0.06% 287
2022
Q4
$373M Sell
3,053,605
-618,621
-17% -$75.6M 0.07% 252
2022
Q3
$379M Buy
3,672,226
+123,089
+3% +$12.7M 0.08% 235
2022
Q2
$330M Sell
3,549,137
-1,116,442
-24% -$104M 0.07% 261
2022
Q1
$548M Buy
4,665,579
+594,855
+15% +$69.8M 0.09% 210
2021
Q4
$548M Buy
4,070,724
+125,480
+3% +$16.9M 0.09% 221
2021
Q3
$629M Buy
3,945,244
+510,971
+15% +$81.4M 0.11% 191
2021
Q2
$452M Sell
3,434,273
-58,060
-2% -$7.64M 0.08% 249
2021
Q1
$450M Buy
3,492,333
+90,775
+3% +$11.7M 0.08% 241
2020
Q4
$567M Buy
3,401,558
+149,797
+5% +$25M 0.1% 198
2020
Q3
$502M Buy
3,251,761
+1,465,470
+82% +$226M 0.1% 183
2020
Q2
$264M Buy
1,786,291
+116,145
+7% +$17.2M 0.06% 282
2020
Q1
$188M Sell
1,670,146
-47,189
-3% -$5.31M 0.05% 314
2019
Q4
$239M Buy
1,717,335
+923,269
+116% +$128M 0.05% 353
2019
Q3
$76.5M Buy
794,066
+674,527
+564% +$65M 0.02% 606
2019
Q2
$13.8M Buy
119,539
+9,962
+9% +$1.15M ﹤0.01% 1111
2019
Q1
$12.9M Buy
109,577
+60,879
+125% +$7.17M ﹤0.01% 1137
2018
Q4
$3.05M Buy
48,698
+5,467
+13% +$343K ﹤0.01% 1521
2018
Q3
$3.06M Sell
43,231
-16,090
-27% -$1.14M ﹤0.01% 1596
2018
Q2
$3.95M Buy
59,321
+41,786
+238% +$2.78M ﹤0.01% 1559
2018
Q1
$1.15M Buy
+17,535
New +$1.15M ﹤0.01% 1872